200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 53597-69-6

53597-69-6

53597-69-6 | 1,3,5-Triaza-7-phosphaadamantane

CAS No: 53597-69-6 Catalog No: AG003DGD MDL No:MFCD00154905

Product Description

Catalog Number:
AG003DGD
Chemical Name:
1,3,5-Triaza-7-phosphaadamantane
CAS Number:
53597-69-6
Molecular Formula:
C6H12N3P
Molecular Weight:
157.1533
MDL Number:
MFCD00154905
IUPAC Name:
1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]decane
InChI:
InChI=1S/C6H12N3P/c1-7-2-9-3-8(1)5-10(4-7)6-9/h1-6H2
InChI Key:
FXXRPTKTLVHPAR-UHFFFAOYSA-N
SMILES:
C1N2CN3CN1CP(C2)C3
NSC Number:
266642

Properties

Complexity:
123  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
157.077g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
157.157g/mol
Monoisotopic Mass:
157.077g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
9.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0

Literature

Title Journal
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors. International journal of pharmaceutics 20120715
Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage. Dalton transactions (Cambridge, England : 2003) 20120628
Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties. Dalton transactions (Cambridge, England : 2003) 20111107
Synthesis, antimicrobial and antiproliferative activity of novel silver(I) tris(pyrazolyl)methanesulfonate and 1,3,5-triaza-7-phosphadamantane complexes. Inorganic chemistry 20111107
The Suzuki reaction in aqueous media promoted by P, N ligands. Molecules (Basel, Switzerland) 20110725
Organometallic ruthenium(II) arene compounds with antiangiogenic activity. Journal of medicinal chemistry 20110609
Synthesis, structures and in vitro cytotoxicity of some cationic cis-platinum(II) complexes containing chelating thiocarbamates. Journal of inorganic biochemistry 20110301
Water-soluble Cp ruthenium complex containing 1,3,5-triaza-7-phosphaadamantane and 8-thiotheophylline derivatives: synthesis, characterization, and antiproliferative activity. Inorganic chemistry 20110207
In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands. Journal of inorganic biochemistry 20110201
Copper and its complexes in medicine: a biochemical approach. Molecular biology international 20110101
Antitumor activity of new hydridotris(pyrazolyl)borate ruthenium(II) complexes containing the phosphanes PTA and 1-CH3-PTA. Dalton transactions (Cambridge, England : 2003) 20101114
Iron(II) and ruthenium(II) complexes containing P, N, and H ligands: structure, spectroscopy, electrochemistry, and reactivity. Inorganic chemistry 20101018
Counterion-dependent deuteration of pentamethylcyclopentadiene in water-soluble cationic Rh(III) complexes assisted by PTA. Dalton transactions (Cambridge, England : 2003) 20100414
Electronic and geometric effects of phosphatriazaadamantane ligands on the catalytic activity of an [FeFe] hydrogenase inspired complex. Dalton transactions (Cambridge, England : 2003) 20100328
Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands. ChemMedChem 20100101
Excellent correlation between cathepsin B inhibition and cytotoxicity for a series of palladacycles. Dalton transactions (Cambridge, England : 2003) 20091228
An organometallic approach for the synthesis of water-soluble ruthenium and platinum nanoparticles. Dalton transactions (Cambridge, England : 2003) 20091214
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands. Journal of inorganic biochemistry 20091201
Intramolecular hydrogen-bonded tertiary phosphines as 1,3,5-triaza-7-phosphaadamantane (PTA) analogues. Inorganic chemistry 20090316
Facile modification of 1,3,5-triaza-7-phosphatricyclo[3.3.1.1(3,7)]decane phosphanes coordinated to ruthenium(II). Inorganic chemistry 20090316
Laser spectroscopy for atmospheric and environmental sensing. Sensors (Basel, Switzerland) 20090101
New water-soluble azido- and derived tetrazolato-platinum(II) complexes with PTA. Easy metal-mediated synthesis and isolation of 5-substituted tetrazoles. Dalton transactions (Cambridge, England : 2003) 20081214
Complexes of the [Re(6)(mu(3)-Se)(8)](2+) core-containing clusters with the water-soluble 1,3,5-triaza-7-phosphaadamantane (PTA) ligand: unexpected ligand protonation and related studies. Dalton transactions (Cambridge, England : 2003) 20081121
Cu(I) complexes bearing the new sterically demanding and coordination flexible tris(3-phenyl-1-pyrazolyl)methanesulfonate ligand and the water-soluble phosphine 1,3,5-triaza-7-phosphaadamantane or related ligands. Inorganic chemistry 20081103
The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20080901
DNA structural distortions induced by ruthenium-arene anticancer compounds. Journal of the American Chemical Society 20080820
Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands. X-ray crystal structures of [Au(SC4H3N2)(PTA)], trans-[Pt(SC4H3N2)2(PTA)2], trans-[Pt(SC5H4N)2(PTA)2], and trans-[Pt(SC5H4N)2(DAPTA)2]. Inorganic chemistry 20080707
Three-dimensional hydrogen-bonded supra-molecular assembly in tetrakis-(1,3,5-triaza-7-phosphaadamantane)copper(I) chloride hexa-hydrate. Acta crystallographica. Section E, Structure reports online 20080501
Extending the coordination chemistry of 1,3,5-triaza-7-phosphaadamantane (PTA) to cobalt centers: first examples of co-PTA complexes and of a metal complex with the PTA oxide ligand. Inorganic chemistry 20080421
1-Methyl-1-azonia-3,5-diaza-7-phosphatricyclo-[3.3.1.1]decane tetra-fluoro-borate. Acta crystallographica. Section E, Structure reports online 20080301
Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20080201
1-Methyl-1-azonia-3,5-diaza-7-phospha-tricyclo-[3.3.1.1]decane 7-oxide triiodide. Acta crystallographica. Section E, Structure reports online 20080201
Insertion of CO2, ketones, and aldehydes into the C-Li bond of 1,3,5-triaza-7-phosphaadamantan-6-yllithium. Inorganic chemistry 20080121
Diastereomerically enriched analogues of the water-soluble phosphine PTA. Synthesis of phenyl(1,3,5-triaza-7-phosphatricyclo[3.3.1.1(3,7)]dec-6-yl)methanol (PZA) and the sulfide PZA(S) and X-ray crystal structures of the oxide PZA(O) and [Cp*IrCl(2)(PZA)]. Inorganic chemistry 20080107
Water-soluble and stable dinitrogen phosphine complexes trans-[ReCl(N2)(PTA-H)n(PTA)4-n]n+ (n = 0-4), the first with 1,3,5-triaza-7-phosphaadamantane. Dalton transactions (Cambridge, England : 2003) 20080107
Development of a series of P(CH(2)N=CHR)(3) and trisubstituted 1,3,5-Triaza-7-phosphaadamantane ligands. Inorganic chemistry 20071224
Tuning the hydrophobicity of ruthenium(II)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy. Dalton transactions (Cambridge, England : 2003) 20071121
Isomerization of trans-[Ru(PTA)4Cl2] to cis-[Ru(PTA)4Cl2] in water and organic solvent: revisiting the chemistry of [Ru(PTA)4Cl2]. Inorganic chemistry 20070820
Phosphinic platinum complexes with 8-thiotheophylline derivatives: synthesis, characterization, and antiproliferative activity. Inorganic chemistry 20070514
Synthesis and coordination chemistry of a novel bidentate phosphine: 6-(diphenylphosphino)-1,3,5-triaza-7-phosphaadamantane (PTA-PPh2). Inorganic chemistry 20060821
Manganese complexes of 1,3,5-triaza-7-phosphaadamantane (PTA): the first nitrogen-bound transition-metal complex of PTA. Inorganic chemistry 20060501
Synthesis, characterization, and DNA binding of new water-soluble cyclopentadienyl ruthenium(II) complexes incorporating phosphines. Inorganic chemistry 20060206
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes. Journal of medicinal chemistry 20050616
The hydrophilic phosphatriazaadamantane ligand in the development of H2 production electrocatalysts: iron hydrogenase model complexes. Journal of the American Chemical Society 20040929
Reactions of [Ru(H(2)O)(6)](2+) with water-soluble tertiary phosphines. Dalton transactions (Cambridge, England : 2003) 20040807
cis-Diphenylbis(1,3,5-triaza-7-phosphaadamantane-kappaP)platinum(II). Acta crystallographica. Section C, Crystal structure communications 20040601
Synthesis and structures of nickel and palladium salicylaldiminato 1,3,5-triaza-7-phosphaadamantane (PTA) complexes. Inorganic chemistry 20031020
Trans-bis(3,5-diaza-1-azonia-7-phosphaadamantane-kappaP)bis(thiocyanato-kappaS)palladium(II) bis(thiocyanate). Acta crystallographica. Section C, Crystal structure communications 20030901
Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane). Chemical communications (Cambridge, England) 20030121
Syntheses, structure, and photoluminescence properties of the 1-dimensional chain compounds [(TPA)(2)Au][Au(CN)(2)] and (TPA)AuCl (TPA = 1,3,5-triaza-7-phosphaadamantane). Inorganic chemistry 20021202
trans-Diiodobis(1,3,5-triaza-7-phosphaadamantane)platinum(II). Acta crystallographica. Section C, Crystal structure communications 20010501
Synthesis and characterization of iridium 1,3,5-triaza-7-phosphaadamantane (PTA) complexes. X-ray crystal and molecular structures of [Ir(PTA)4(CO)]Cl and [Ir(PTAH)3(PTAH2)(H)2]Cl6. Inorganic chemistry 20010129

Related Products

© 2019 Angene International Limited. All rights Reserved.